Aberrant methylation and downregulation of sall3 in human hepatocellular carcinoma

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 21

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

297

HTML

2518

Figures (1-5)

132

Sum=2947

Jun 7, 2012 (publication date) through May 18, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Jun 7, 2012; 18(21): 2719-2726
Published online Jun 7, 2012. doi: 10.3748/wjg.v18.i21.2719

Full Size Figure Download Figure

Figure 4 Quantitative methylation analysis on each CpG unit of sall3 CpG island in HCC cells after 5-Aza-CdR treatment or control (A-F).

Citation: Yang XX, Sun JZ, Li FX, Wu YS, Du HY, Zhu W, Li XH, Li M. Aberrant methylation and downregulation of sall3 in human hepatocellular carcinoma. World J Gastroenterol 2012; 18(21): 2719-2726
URL: https://www.wjgnet.com/1007-9327/full/v18/i21/2719.htm
DOI: https://dx.doi.org/10.3748/wjg.v18.i21.2719